Amorolfine Hydrochloride is an antifungal drug developed by the U.S. Food And Drug Administration and initially approved on 17 Dec 1999 for treating dermatomycoses.

Amorolfine Hydrochloride is used for treating fungal skin infections caused by dermatophytes (fungi infecting the skin).

Apply enough Amorolfine Hydrochloride evenly on the affected skin and the surrounding area. Rub it in gently until it is absorbed. Wash your hands thoroughly after application. Avoid contact with eyes. Apply once or twice daily or as your doctor recommends.

The side effects known to occur commonly during the treatment with Amorolfine Hydrochloride are skin redness, burning, and itching.

Do not use this drug if you have a known allergy or sensitivity to it or any components in the medication. Amorolfine Hydrochloride is intended for topical use on the skin affected by fungal infections and should not be applied to mucous membranes (e.g., mouth and nostrils), ears, or eyes. Contact with these sensitive areas can lead to irritation or adverse reactions. If accidental contact occurs, thoroughly rinse the affected area with water.

It's generally recommended to avoid using regular nail polish or nail varnish while using this drug. These products can interfere with the medication's effectiveness. There is insufficient data available regarding the use of this drug in pregnant and nursing women, and the risks to breastfeeding infants are unknown. Due to a lack of safety data, the use of Amorolfine Hydrochloride is not recommended for pediatric patients (children and infants). The safety and effectiveness of this medication in children have yet to be adequately studied.

Before applying Amorolfine Hydrochloride, gently clean the affected skin area with mild soap and water. Ensure that the skin is thoroughly dry before applying the medication. Do not apply more or less than the recommended amount, and continue using the medication for the entire prescribed duration, even if you start to feel better before the treatment is complete. Fungal infections can recur if not fully treated.

1. Ciplamed; [Accessed on 7th Sep 2023], https://ciplamed.com/content/strafos-cream
2. Manasi Banerjee et al.; Comparative evaluation of effectivity and safety of topical amorolfine and clotrimazole in the treatment of tinea corporis; Indian Journal of Dermatology; Published on Nov 2011; [Accessed on 7th Sep 2023], http://www.ncbi.nlm.nih.gov/pmc/articles/pmc3276891/

The drug information on this page is not a substitute for medical advice; it is meant for educational purposes only. For further details, consult your doctor about your medical condition to know if you are eligible to receive this treatment.